ClinicalTrials.Veeva

Menu

Subclinical Hypothyroidism and Normogonadotropic Anovulation

J

Jagiellonian University

Status

Completed

Conditions

Polycystic Ovary Syndrome
Hypothalamic-Pituitary-Ovarian Axis Dysfunction (Disorder)

Treatments

Other: Comparison of laboratory test results in women in the 4 study arms

Study type

Observational

Funder types

Other

Identifiers

NCT05782725
1072.6120.172.2022

Details and patient eligibility

About

Thyroid hormones (TH) can modify the functioning of the hypothalamic-pituitary-ovarian axis, affecting the functions of granulosa cells and the development and apoptosis of preantral follicles. TH receptors are present within the oocytes, and TH and anti-thyroid antibodies (ATA) are present in the follicular fluid. Improper thyroid function can cause ovulation disorders, luteal phase failure, impaired endometrial receptivity and result in implantation failures and recurrent miscarriages. While overt hypothyroidism is treated to improve fertility, the effect of subclinical hypothyroidism (SCH) and the presence of circulating ATAs on fertility and obstetric outcomes is uncertain and data on ovarian reserve rates are conflicting. Among the causes of ovulation disorders (group II according to the WHO classification), polycystic ovary syndrome (PCOS) dominates, found in 3-15% of women of reproductive age, and the remaining group of causes is the so-called Hypothalamic-Pituitary-Ovarian Axis Dysfunction (HPOD). The exact etiology of both entities is unknown.

Full description

Purpose of the study

Evaluation of ovarian reserve indices in women with normogonadotropic anovulation with SCH and without thyroid disease.

Detailed objectives

i) Assessment of AMH, FSH, LH, estradiol, astral follicle count (AFC)/ovarian volume in the subpopulation of women with PCOS and SCH compared to women with PCOS without thyroid disease ii) Assessment of AMH, FSH, LH, estradiol, AFC/ovarian volume in the subpopulation of women with HPOD (other than PCOS) with SCH compared to women with HPOD without thyroid disease iii) Comparison of AMH, FSH, LH, estradiol, AFC/ovarian volume in women with PCOS and HPOD with and without thyroid disease and evaluation of correlation with US ovarian morphology iv) Calculation of the cut-off point of AMH concentration correlating with a high probability of PCOS diagnosis and TSH correlating with unfavorable parameters of ovarian function/HPO axis.

Enrollment

300 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18-45
  • irregular periods
  • infertility due to ovulation disorders
  • euthyreosis

Exclusion criteria

  • diagnosed and treated thyroid dysfunction,
  • history of thyroidectomy

Trial design

300 participants in 4 patient groups

1
Description:
PCOS and SCH
Treatment:
Other: Comparison of laboratory test results in women in the 4 study arms
2
Description:
PCOH without SCH
Treatment:
Other: Comparison of laboratory test results in women in the 4 study arms
3
Description:
HPOD and SCH
Treatment:
Other: Comparison of laboratory test results in women in the 4 study arms
4
Description:
HPOD without SCH
Treatment:
Other: Comparison of laboratory test results in women in the 4 study arms

Trial contacts and locations

1

Loading...

Central trial contact

Robert Jach, Prof.; Iwona M. Gawron, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems